Banner

Study of serum Granzyme B in heavy cigarette smokers with and without chronic obstructive pulmonary disease

• 2014
Back
Publication Information
Authors Ahmed A. Yousef a,b, Mahmoud M. Alsalahy a, Mohammad A. Almahdy a, Tarek S. Essawy a,*, Khalid M. Belal
Keywords Not Available
Journal Not Available
Publisher Not Available
Volume Not Available
Issue Not Available
Pages Not Available
publication.type Local
Paper Link Open Link
Supplementary Materials Not Available
Abstract
Background: Inflammation of the airways is present in COPD with increased number of
inflammatory cells including killer cells that lyse their target cells by two mechanisms; membranolysis
in which secreted molecules such as granzymes form pores in the membrane of target cells; and
apoptosis. Granzyme B has the strongest apoptotic activity of all granzymes.
Aim of this work: Aim of this work was to study the relation between Granzyme B, tobacco
smoking and chronic obstructive pulmonary disease.
Methods: The study included 40 clinically stable COPD patients classified according to GOLD
(2013) criteria into two groups; moderate (GOLD II) and severe (GOLD III) plus 40 apparently
healthy control subjects (20 smokers and 20 nonsmokers). Pulmonary function results and serum
levels of Granzyme B (measured by ELISA) were recorded.
Results: Granzyme B levels are elevated in COPD. Cigarette smoking appears to be a direct
stimulus to Granzyme B production. Granzyme B could play a role in the pathogenesis of COPD.
Aging seems to be a risk factor for Granzyme B production and pathogenesis of COPD.
Conclusion: Granzyme B levels are elevated in COPD. Cigarette smoking appears to be a direct
stimulus to Granzyme B production. Granzyme B could play a role in the pathogenesis of COPD.
Aging seems to be a risk factor for Granzyme B production and pathogenesis of COPD